800 million people. Severely underserved healthcare. A university-backed incubator with grant approvals, clinical infrastructure, and a founding team ready to build. This is the ground floor.
The Opportunity
Growing at 22% CAGR — driven largely by Tier-2 and rural demand
Outside India's top-8 cities with limited access to modern medtech solutions
Despite this market representing the majority of India's healthcare burden
Bareilly's cost structure gives startups more runway for the same investment
Why Now
PLI for medtech, Ayushman Bharat, National Digital Health Mission — all driving capital and attention toward underserved healthcare markets.
BIU's hospital, labs, and faculty are already in place. We're not building from scratch — we're activating what exists.
The ₹1.2 lakh crore global herbal and nutraceutical market has no credible scientifically-validated Indian pipeline. BMIIL's Ayush track is built to supply one.
No comparable medtech incubator exists in Uttar Pradesh, India's most populous state. The addressable market is uncrowded and large.
Participation Models
Direct equity participation in BMIIL's fund structure or co-investment rights into individual portfolio startups at pre-negotiated terms.
Gain privileged access to BMIIL's innovation pipeline — with rights to pilot, license, or acquire technologies developed within the incubator.
We actively pursue and facilitate DST, BIRAC, Startup India, and international grant pipelines for our portfolio companies and for BMIIL itself.
Download our investor deck or reach out directly for a tailored conversation.